Fungal infections affect virtually every person on Earth at some point, from a passing bout of athlete’s foot to life-threatening bloodstream invasions that kill hundreds of thousands each year. Fungi are ancient organisms that have co-evolved alongside animals and plants for hundreds of millions of years, and the strategies they use to colonize living tissue are remarkably diverse. Understanding fungal infection means grappling with a range of diseases that share a kingdom of origin but differ wildly in severity, location, and the populations they threaten.
How Fungi Break Into the Body
Fungi that cause disease in humans generally fall into two broad camps: those that stay on the surface and those that invade deeper tissues. Superficial infections are caused mostly by dermatophytes, a group of molds that have evolved a specific toolkit for digesting keratin, the tough structural protein in skin, hair, and nails. They attach to the outer skin surface, penetrate into sublayers using specialized fungal filaments, and secrete enzymes that break down keratin and elastin for nutrition.1Medical Mycology. Infection stages of the dermatophyte pathogen Trichophyton: microscopic characterization and proteolytic enzymes The result is the itchy, scaly, ring-shaped patches known as tinea infections, commonly called ringworm, jock itch, or athlete’s foot depending on where they appear.2Medical Mycology. Keratin hydrolysis by dermatophytes
Deeper infections involve a different set of organisms with more elaborate tricks. Many of the most dangerous human-pathogenic fungi are thermally dimorphic, meaning they change their physical form depending on temperature. In the soil at cooler temperatures (around 22–25°C), they grow as molds with branching filaments. Once inhaled or introduced into the warm human body at 37°C, they shift into a yeast form better suited for evading the immune system and surviving in tissue.3PubMed Central. Fungal Dimorphism and Virulence: Molecular Mechanisms for Temperature Adaptation, Immune Evasion, and In Vivo Survival This shape-shifting ability is central to the biology of fungi like Histoplasma, Blastomyces, and Coccidioides, all of which can cause serious lung infections after a person breathes in spores from contaminated soil.
How Your Immune System Recognizes Fungi
The human immune system has a dedicated surveillance apparatus for detecting fungal invaders, and much of it revolves around recognizing components of the fungal cell wall. The cell wall of most pathogenic fungi contains β-glucan, a sugar polymer that mammalian cells do not produce. A receptor called Dectin-1, found on immune cells like macrophages and neutrophils, acts as the primary sensor for β-glucan.4PubMed. β-glucan: Crucial component of the fungal cell wall and elusive MAMP in plants When Dectin-1 locks onto β-glucan on a fungal surface, it triggers the immune cell to engulf the invader and release inflammatory signals that recruit more defenders.5Immunity. Fungal β-Glucans and Mammalian Immunity
This system works well in healthy people, which is why most fungal exposures never progress to disease. But when the immune system is compromised, whether by HIV, cancer chemotherapy, organ transplant drugs, or uncontrolled diabetes, the door swings wide open for opportunistic fungal infections. That relationship between immune status and fungal disease is the single most important concept in medical mycology: the vast majority of fatal fungal infections happen in people whose defenses are already weakened.
When Fungi Invade the Brain and Organs
Among the most feared invasive fungal infections is cryptococcal meningitis, caused by Cryptococcus neoformans. This yeast is found worldwide in soil and bird droppings, and after being inhaled, it can spread through the bloodstream and cross into the brain. Researchers have identified a secreted fungal enzyme called Mpr1 that is required for the organism to breach the blood-brain barrier. When the gene for this enzyme is deleted in lab strains, the fungus loses its ability to penetrate brain tissue.6PubMed Central. Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease More recent work suggests that the fungus also hijacks a host signaling pathway in brain blood-vessel cells, manipulating those cells to facilitate its own passage across the barrier.7PubMed. Cryptococcus neoformans and the EGFR Puzzle: Uncovering a Novel mechanism for blood-brain barrier crossing Cryptococcal meningitis remains a leading cause of death in people with advanced HIV, particularly in sub-Saharan Africa.
Mucormycosis, caused by molds in the order Mucorales, gained global attention during the COVID-19 pandemic. In countries like India, waves of mucormycosis cases appeared in hospitalized COVID patients, particularly those with uncontrolled diabetes and high blood sugar. The pathophysiology involved multiple converging factors: high serum iron, disrupted iron metabolism, and elevated glucose all create an environment where Mucorales fungi thrive.8PubMed Central. Current Understanding in the Pathophysiology of SARS-CoV-2-Associated Rhino-Orbito-Cerebral Mucormycosis: A Comprehensive Review The infection typically starts in the sinuses and can rapidly spread to the eye socket and brain, making early diagnosis and aggressive surgery critical for survival.
Candida auris and Hospital Outbreaks
If one fungal pathogen keeps infectious-disease specialists up at night, it is Candida auris. First identified in 2009, this yeast has spread to healthcare facilities on every inhabited continent. What makes it so alarming is a combination of traits that seem almost designed for hospital persistence: it resists multiple classes of antifungal drugs, it survives on surfaces for weeks, it colonizes patients’ skin for prolonged periods, and it transmits efficiently between patients in healthcare settings.9PubMed. Candidozyma auris (formerly Candida auris): resistant, long lasting, and everywhere Its thermotolerance is striking: it grows optimally at 37°C and remains viable at temperatures up to 42°C, tolerates high salt, and forms cell clusters that are difficult to dislodge from surfaces.10PLoS Pathogens. Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally
Outbreaks in intensive care units and long-term care facilities have proven extremely difficult to contain. Standard hospital disinfection protocols often fail to eliminate C. auris from environmental surfaces, requiring specialized cleaning agents. The organism primarily causes bloodstream infections in people who are already critically ill, and mortality rates are high.11PubMed Central. The rising challenge of Candida auris: insights into its transmission, drug resistance, and infection control strategies Recent taxonomic reclassification of the organism has added further confusion to surveillance efforts, since labs that are not specifically looking for it may miss it entirely.
Biofilms on Medical Devices
One reason hospital fungal infections are so stubborn is biofilm formation. Candida species, including C. auris and the more common C. albicans, readily form biofilms on the surfaces of catheters, heart valves, joint replacements, and other implanted devices. A biofilm is essentially a structured community of fungal cells encased in a self-produced sticky matrix made primarily of polysaccharides.12PubMed. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance Once the biofilm matures, the cells inside become dramatically less susceptible to antifungal drugs.13PubMed Central. Candida Biofilms: Development, Architecture, and Resistance
Two specific components of the biofilm matrix, β-glucan and extracellular DNA, actively promote drug resistance by physically shielding cells and sequestering antifungal molecules before they reach their targets.14PubMed Central. Mechanisms of Candida biofilm drug resistance In practice, this means that a catheter-related Candida infection often cannot be cured with drugs alone. The device itself usually has to be removed.
The Antifungal Resistance Problem
Resistance to antifungal drugs is not limited to Candida auris. Aspergillus fumigatus, the most common mold behind invasive lung infections, has been developing resistance to azole antifungals at a worrying pace. The dominant resistance mechanism involves mutations in a gene called cyp51A combined with a genetic insertion in the gene’s control region. The most common variants, known by shorthand like TR34/L98H, have been found in clinical samples across multiple continents.15PubMed Central. Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene16PubMed Central. Azole Resistance and cyp51A Mutation of Aspergillus fumigatus in a Tertiary Referral Hospital in Taiwan
The unsettling part is that this resistance appears to originate in the environment, not in patients receiving treatment. The same azole chemicals used in clinical medicine are also used as agricultural fungicides sprayed on crops. Aspergillus fumigatus living in agricultural soil encounters these compounds, and resistant strains emerge and spread through airborne spores. A patient who has never taken an antifungal drug in their life can inhale a resistant strain and face a much more difficult infection.17PubMed. Azole-resistant Aspergillus fumigatus: A global phenomenon originating in the environment? This link between agricultural fungicide use and clinical drug resistance is one of the clearest examples of a One Health problem, where human health, animal health, and environmental practices are inextricably connected.
Diagnosing Invasive Fungal Infections
Diagnosing a superficial fungal infection is usually straightforward: a doctor can often recognize it by appearance and confirm it with a simple skin scraping under a microscope. Invasive infections are a different story. Growing fungi from blood cultures is slow, taking days or even weeks, and many deep fungal infections never show up in standard blood cultures at all. The clinical symptoms, mainly fever and organ dysfunction in a sick, immunocompromised person, overlap heavily with bacterial infections.
Blood tests that detect fungal cell-wall components have become important tools for early diagnosis. The β-D-glucan (BDG) assay detects the same molecule your immune system uses to spot fungi, and because β-glucan is shared across a wide range of species including Candida, Aspergillus, and Pneumocystis, a single test can flag infections caused by many different fungi.18PubMed Central. β-D-glucan testing is important for diagnosis of invasive fungal infections One tertiary-care evaluation found that BDG testing had a sensitivity above 97% and specificity above 96% for distinguishing invasive fungal infections from non-fungal causes.19Indian Journal of Medical Microbiology. Evaluation of Biomarkers: Galactomannan and 1,3-Beta-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections in Immunocompromised Patients from a Tertiary Care Centre However, false positives can occur with certain hemodialysis filters and some antibiotics, so test results still need to be interpreted alongside the clinical picture.20PubMed Central. β-D-glucan testing is important for diagnosis of invasive fungal infections
For Aspergillus infections specifically, a second test that detects galactomannan (a different cell-wall sugar) can help confirm the diagnosis. Both BDG and galactomannan tests serve as adjuncts rather than standalone diagnostics; their accuracy varies across different patient populations, and neither replaces the need for imaging and clinical judgment.21PubMed Central. Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis
Treatment Trade-offs and New Drugs
Treating serious fungal infections has always been harder than treating bacterial ones. The fundamental problem is that fungi are eukaryotes, just like us. Their cellular machinery is far more similar to human cells than bacteria are, which makes it difficult to find drug targets that kill the fungus without harming the patient. The antifungal arsenal is correspondingly thin: while doctors have dozens of antibiotic classes to choose from, there are only a handful of antifungal drug classes available.
Amphotericin B, introduced in the 1950s, remains the backbone for many life-threatening invasive infections. It works by binding to a sterol in the fungal cell membrane, punching holes in it. The catch is that it also damages human kidney cells, and kidney toxicity has been the drug’s defining limitation for decades.22PubMed. Amphotericin B nephrotoxicity Lipid-based formulations developed later package the drug in a way that reduces kidney damage while maintaining its antifungal potency. Clinical trials have consistently shown that lipid formulations are significantly less toxic to the kidneys than the conventional version, with at least equivalent effectiveness.23PubMed. Amphotericin B formulations: a comparative review of efficacy and toxicity The trade-off is cost: lipid amphotericin formulations are far more expensive, which limits access in the low-income countries where fungal deaths are most concentrated.
The pipeline of new antifungal agents is busier than it has been in years. Several drugs with novel mechanisms of action are in advanced development, targeting fungal enzymes and pathways that existing drugs do not touch. These include inhibitors of a fungal enzyme called Gwt1 involved in cell-wall assembly, new compounds that target fungal glucan synthesis differently from existing echinocandins, and agents active against mold infections through entirely new mechanisms.24PubMed Central. The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin Some of these have already received regulatory approval, and the hope is that new drug classes will provide options when resistance makes existing drugs unreliable.
Research into antifungal vaccines is also advancing, though no vaccine for a human fungal infection has yet been approved. Most efforts focus on recombinant subunit vaccines that present pieces of fungal proteins to the immune system to prime a protective response, with several candidates in preclinical and early clinical testing.25PubMed. Recombinant subunit vaccines against invasive fungal infections: mechanisms, development progress, and therapeutic potential
Climate Change and New Fungal Threats
One of the more alarming hypotheses in infectious disease is that rising global temperatures could expand the roster of fungi capable of infecting mammals. Most fungi cannot grow at 37°C, which is one of the main reasons mammals are relatively resistant to fungal disease compared to insects, amphibians, and plants. The concern is that as environmental temperatures climb, fungi that currently cannot survive at body temperature may gradually adapt to warmer conditions, crossing the thermal threshold needed to infect warm-blooded hosts.26PubMed Central. Global warming will bring new fungal diseases for mammals At the same time, the geographic ranges of currently pathogenic species may shift into regions where populations have no prior exposure.27PubMed Central. Global warming could drive the emergence of new fungal pathogens
Some researchers have speculated that C. auris itself may be a product of this process, a formerly environmental organism that adapted to higher temperatures and then entered the human niche. The evidence is circumstantial, but the timing is suggestive: C. auris appeared simultaneously on multiple continents with no obvious epidemiological link between the earliest cases, as though environmental pressure had independently nudged the species toward pathogenicity in several places at once.
Fungi in Your Gut
Not all fungi in the body are invaders. Like bacteria, fungi are a normal part of the human microbiome, particularly in the gut. In healthy adults, the most abundant fungal genera in the intestine are Candida, Saccharomyces, and Cladosporium. The fungal community, sometimes called the mycobiome, appears to interact with gut bacteria in ways that influence health. When the balance tips, particularly when Candida species increase, bacterial diversity tends to decrease. This inverse relationship has been consistently observed in conditions associated with urbanized lifestyles, including obesity and inflammatory bowel disease.28The Lancet Microbe. The gut mycobiome in health and disease
Whether Candida overgrowth is a cause or a consequence of these conditions is still being worked out. But the finding underscores that fungi are not simply pathogens waiting to strike. They are part of the body’s ecosystem, and their role in health is just beginning to be understood.
Fungi Beyond Human Disease
Human medicine captures most of the attention, but fungal infections shape ecosystems, agriculture, and food safety in ways that ripple through entire societies.
In agriculture, the rice blast fungus Magnaporthe oryzae is one of the most destructive crop pathogens on the planet. It produces a specialized infection cell called an appressorium that generates enormous pressure to physically punch through the plant cell wall and invade rice leaf tissue.29Nature Microbiology. Appressorium-mediated plant infection by Magnaporthe oryzae is regulated by a Pmk1-dependent hierarchical transcriptional network Rice is a staple food for roughly half the world’s population, and blast disease can devastate harvests in tropical and subtropical regions.
In food safety, certain molds in the genus Aspergillus produce aflatoxins, among the most potent naturally occurring carcinogens. Aflatoxin B1, which contaminates grains, peanuts, and tree nuts when they are stored in warm, humid conditions, is metabolized in the liver into a reactive compound that binds directly to DNA. This binding causes mutations in a tumor-suppressor gene at a specific location that has been found repeatedly in liver cancer cases.30PubMed Central. Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention31IntechOpen. The Carcinogenicity of Aflatoxin B1 Chronic aflatoxin exposure is a major contributor to liver cancer in parts of sub-Saharan Africa and Southeast Asia, where food-storage infrastructure and regulatory testing are limited.
Wildlife has not been spared either. Chytridiomycosis, caused by the aquatic fungus Batrachochytrium dendrobatidis, has driven catastrophic declines in amphibian populations worldwide. The fungus infects the skin of frogs and salamanders, and because amphibians rely on their skin for electrolyte balance, infection disrupts the transport of sodium and potassium across the epidermis. In severely affected frogs, plasma sodium drops by roughly 20% and potassium by about 50%, ultimately causing the heart to stop.32PubMed. Pathogenesis of chytridiomycosis, a cause of catastrophic amphibian declines33PubMed Central. Frog skin epithelium: electrolyte transport and chytridiomycosis Hundreds of amphibian species have been affected, and some have gone extinct.
Zoonotic Transmission and Unusual Routes of Entry
Most people acquire fungal infections either by inhaling spores or through direct skin contact with contaminated surfaces. But some infections enter through more unexpected routes. Sporotrichosis, caused by Sporothrix species, is classically associated with thorn pricks and handling plant material, earning it the nickname “rose gardener’s disease.” In Brazil, however, a massive ongoing epidemic is driven primarily by cats. Cats develop severe sporotrichosis lesions, and the fungus transmits to humans through bites and scratches. Brazil now bears the highest global burden of both feline and human sporotrichosis.34PubMed. Nosocomial transmission of Sporothrix brasiliensis in two cats
Insect-pathogenic fungi offer perhaps the most striking example of fungal infection strategies. Certain species, sometimes called zombie-making fungi, infect insects and manipulate their behavior in ways that maximize spore dispersal. Infected ants and flies exhibit heightened activity, climb to elevated positions, and adopt body postures that help the fungus release its spores into the environment. These behavioral changes follow a specific circadian timing, suggesting the fungus is not just killing the host but actively hijacking its nervous system on a schedule.35PubMed Central. Mechanisms behind the Madness: How Do Zombie-Making Fungal Entomopathogens Affect Host Behavior To Increase Transmission? While these fungi pose no threat to humans, they illustrate the sophistication of fungal parasitism and the evolutionary pressure fungi have faced to solve the problem of spreading to new hosts.